Common Contracts
1 similar Clinical Study Agreement contracts
ContractClinical Study Agreement • December 5th, 2018
AMENDMENT No. 2 TO THECLINICAL STUDY AGREEMENT Protocol # DS 1040-A-U103 DODATEK č. 2 KE SMLOUVĚO KLINICKÉ STUDII Číslo protokolu: DS 1040-A-U103 This Amendment No. 2 to the Clinical Study Agreement (“Amendment”) by and between Fakultni nemocnice u sv. Anny v Brne, located at Pekarska 664/53, 656 91 Brno - Stare Brno, Czech Republic, represented by MUDr. Martin Pavlík, Ph.D., DESA, EDIC, Director, ID No.: 00159816 (“Study Site”), MUDr. Michal Reif, born on 6.11.1974, located at Kamenna 31, 639 00 Brno, Czech Republic (“Principal Investigator”), and Daiichi Sankyo, Inc., located at 211 Mt. Airy Road, Basking Ridge, New Jersey 07920 (formerly at 399 Thornall Street, Edison, New Jersey 08837) (“DSI”), becomes valid as of date it is signed by all Parties and effective as of date it is published in the Register of Contracts (“Effective Date”). Tento Dodatek č. 2 ke Smlouvě o klinické studii (dále jen „dodatek“) se uzavírá mezi Fakultní nemocnicí u sv. Anny v Brně, se sídlem na adrese Peka
